Researchers identify diabetes drug metformin as potential atrial fibrillation treatment in collaborative research

Researchers have identified a common diabetes medication, metformin, as a possible treatment for atrial fibrillation. They used advanced computation and genetic sequencing to determine that metformin’s targets overlap significantly with genes dysregulated in atrial fibrillation.


Click here for original story, Researchers identify diabetes drug metformin as potential atrial fibrillation treatment in collaborative research


Source: ScienceDaily